FastWave Medical used 2025 to make uncommon progress for an early-stage company, advancing not one but two differentiated IVL platforms — a rare pace in a field where progress often spans years.

EMPOWER CAD, a global prospective, multi-center, real-world study, reaffirms favorable acute outcomes for coronary IVL in female patients, unlike other calcium modification tools PARIS, May 20, 2025 ...

A large number of eyes could be on a fast-growing technology used to modify plaque in arteries as attendees gather in Paris for this year’s EuroPCR. Intravascular lithotripsy (IVL) has become ...

Johnson & Johnson’s Shockwave Medical strengthened its position in the intravascular lithotripsy (IVL) market. The New Brunswick, NJ-based company said earlier this week that it was launching the ...

Novel Intravascular Lithotripsy (IVL) catheter demonstrates ability to modify calcium safely, enabling treatment and crossing of tightly-stenosed lower limb lesions Technology has received U.S. FDA ...

SAN FRANCISCO, CA—The use of cutting and noncompliant balloons for lesion preparation appears to provide results similar to those achieved with Shockwave intravascular lithotripsy (IVL; Shockwave ...

Johnson & Johnson MedTech’s Shockwave Medical has launched its Javelin Peripheral IVL Catheter in the US for peripheral artery disease (PAD). This new intravascular lithotripsy (IVL) platform is ...

Johnson & Johnson shocked the medtech industry early last year when it announced it would acquire Shockwave Medical, a specialist in the intravascular lithotripsy (IVL) market. Shockwave had a huge ...

Johnson & Johnson acquired medtech company Shockwave Medical for $13.1 billion, the pharma giant announced Friday morning. The deal, which has been approved by the board of directors of both companies ...

NEW BRUNSWICK, N.J. & SANTA CLARA, Calif.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) and Shockwave Medical, Inc. (Nasdaq: SWAV) (“Shockwave”) today announced that they have entered into a ...